10x Genomics, Inc. Class A Common Stock (TXG)

Price$31.04

Value ScoreD

Growth ScoreC

Momentum ScoreA

Favorite Metrics

Price vs S&P 500 (26W)57.09%

Price vs S&P 500 (4W)43.71%

VGM Score55.06

Market Capitalization$3.94B

All Metrics

P/CF (Annual)28.97x

Book Value / Share (Quarterly)$6.31

P/TBV (Annual)2.81x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)7.57%

Cash Flow / Share (Quarterly)$0.95

Price vs S&P 500 (YTD)82.15%

Gross Margin (TTM)69.68%

Net Profit Margin (TTM)-3.55%

EPS (TTM)$-0.17

10-Day Avg Trading Volume3.32M

EPS Excl Extra (TTM)$-0.17

Revenue Growth (5Y)16.56%

EPS (Annual)$-0.35

ROI (Annual)-5.47%

Gross Margin (Annual)69.13%

Net Profit Margin (5Y Avg)-24.38%

Cash / Share (Quarterly)$4.19

Revenue Growth QoQ (YoY)-2.61%

ROA (Last FY)-4.18%

Revenue Growth TTM (YoY)2.26%

EBITD / Share (TTM)$-0.00

ROE (5Y Avg)-18.67%

Operating Margin (TTM)-6.06%

Cash Flow / Share (Annual)$1.02

P/B Ratio4.84x

P/B Ratio (Quarterly)3.36x

Net Income / Employee (Annual)$-37,000

EV / Revenue (TTM)5.40x

Net Interest Coverage (TTM)-75.71x

ROA (TTM)-2.23%

EPS Incl Extra (Annual)$-0.35

Current Ratio (Annual)4.46x

Quick Ratio (Quarterly)5.25x

3-Month Avg Trading Volume2.69M

52-Week Price Return240.72%

EV / Free Cash Flow (Annual)26.52x

Revenue / Employee (TTM)$542,300

Tangible BV / Share (Quarterly)$5.85

P/S Ratio (Annual)6.13x

Asset Turnover (Annual)0.62x

52-Week High$35.65

Operating Margin (5Y Avg)-25.48%

EPS Excl Extra (Annual)$-0.35

CapEx CAGR (5Y)-31.16%

Tangible BV CAGR (5Y)0.48%

26-Week Price Return65.02%

Quick Ratio (Annual)3.95x

13-Week Price Return43.44%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)5.90x

Enterprise Value$3.45B

Revenue / Share Growth (5Y)11.78%

Asset Turnover (TTM)0.63x

Book Value / Share Growth (5Y)-1.75%

Revenue / Employee (Annual)$545,700

Inventory Turnover (Annual)2.85x

Pretax Margin (Annual)-6.21%

Cash / Share (Annual)$4.10

3-Month Return Std Dev69.79%

Gross Margin (5Y Avg)72.95%

Net Income / Employee (TTM)$-19,200

ROE (Last FY)-5.47%

Net Interest Coverage (Annual)-66.13x

EPS Basic Excl Extra (Annual)$-0.35

P/FCF (TTM)32.25x

Receivables Turnover (TTM)13.95x

EV / Free Cash Flow (TTM)28.24x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.17

Receivables Turnover (Annual)9.53x

ROI (TTM)-2.86%

P/S Ratio (TTM)6.17x

Pretax Margin (5Y Avg)-23.57%

Revenue / Share (Annual)$5.15

Tangible BV / Share (Annual)$5.75

Price vs S&P 500 (52W)216.36%

Year-to-Date Return90.31%

5-Day Price Return4.90%

EPS Normalized (Annual)$-0.35

ROA (5Y Avg)-14.47%

Net Profit Margin (Annual)-6.77%

Month-to-Date Return9.66%

Cash Flow / Share (TTM)$-1.64

EBITD / Share (Annual)$-0.20

Operating Margin (Annual)-9.49%

LT Debt / Equity (Annual)0.00x

P/CF (TTM)30.83x

ROI (5Y Avg)-18.67%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.17

P/TBV (Quarterly)3.63x

P/B Ratio (Annual)2.59x

Inventory Turnover (TTM)3.02x

Pretax Margin (TTM)-3.01%

Book Value / Share (Annual)$6.24

Price vs S&P 500 (13W)35.18%

Beta2.09x

P/FCF (Annual)30.29x

Revenue / Share (TTM)$4.98

ROE (TTM)-2.86%

52-Week Low$8.95

vGradeD

gGradeC

mGradeA

vgmGradeC

Show chart for

Earnings Surprise History

Q1 26-0.10est. -0.29

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

3.48

3.55

3.64

Industry Peers — Lab Analytical Instruments(24)

Symbol	Value Score	Growth Score	Momentum Score	Price
TXG10x Genomics, Inc. Class A Common Stock	D	C	A	$31.04
AAgilent Technologies Inc.	C	C	B	$135.44
WATWaters Corp	D	C	C	$365.36
ILMNIllumina Inc	D	D	B	$162.32
MTDMettler-Toledo International	D	C	C	$1154.33
RVTYRevvity, Inc.	C	D	C	$98.37
BRKRBruker Corporation	D	D	B	$56.39
BIOBio-Rad Laboratories, Inc.Class A	C	F	B	$294.32
BIO.BBio-Rad Laboratories, Inc. Class B	C	F	B	$304.15
AVTRAvantor, Inc.	B	D	C	$9.16
ALMRAlamar Biosciences, Inc. Common Stock	—	—	A	$20.54

About

10x Genomics develops microfluidic-based instruments, consumables, and software for analyzing biological systems at high resolution and scale. The company's product portfolio includes the Chromium platform, Visium, and Xenium solutions, serving researchers and diagnostics customers globally across North America, Europe, Asia-Pacific, and China.